Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study

BACKGROUND. Direct-acting antivirals (DAA) allow effective and safe eradication of hepatitis C virus (HCV) in most patients. There are limited data on the long-term effects of all-oral, interferon-free DAA combination therapies in kidney transplant (KT) patients infected with HCV. Here we evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Corvillo, Carmen, Beneyto, Isabel, Sánchez-Fructuoso, Ana, Perelló, Manel, Alonso, Angel, Mazuecos, Auxiliadora, Jiménez, Carlos, Zárraga, Sofía, Paul, Javier, Lauzurica, Ricardo, Hernández, Domingo, Guirado, Luis, Franco, Antonio, Ruiz, Juan Carlos, Llorente, Santiago, Crespo, Marta, Rodríguez-Benot, Alberto, de Gracia Guindo, María del Carmen, Díaz-Corte, Carmen, Gentil, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004590/
https://www.ncbi.nlm.nih.gov/pubmed/32095505
http://dx.doi.org/10.1097/TXD.0000000000000954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004590/
https://www.ncbi.nlm.nih.gov/pubmed/32095505
http://dx.doi.org/10.1097/TXD.0000000000000954

Ejemplares similares